Bone Marrow Micro‐Environment in Normal and Deranged Hematopoiesis: Opportunities for Regenerative Medicine and Therapies

• Published in: BioEssays 2018-03, Vol.40 (3), p.n/a
• Main Authors: Sarkaria, Shawn M., Decker, Matthew, Ding, Lei
• Format: Article
• Language: English
• Subjects: Blood diseases; Bone marrow; cross‐talk; Hematological diseases; Hematopoiesis; HSC; Minimal residual disease; New technology; niche; premalignant; Regenerative medicine; treatment
• ISSN: 0265-9247; 1521-1878
• DOI: 10.1002/bies.201700190

Various cell types cooperate to create a highly organized and dynamic micro‐environmental niche in the bone marrow. Over the past several years, the field has increasingly recognized the critical roles of the interplay between bone marrow environment and hematopoietic cells in normal and deranged hematopoiesis. These advances rely on several new technologies that have allowed us to characterize the identity and roles of these niches in great detail. Here, we review the progress of the last several years, list some of the outstanding questions in the field and propose ways to target the diseased environment to better treat hematologic diseases. Understanding the extrinsic regulation by the niche will help boost hematopoiesis for regenerative medicine. Based on natural development of hematologic malignancies, we propose that combinatory targeting the niche and hematopoietic intrinsic mechanisms in early stages of hematopoietic malignancies may help eliminate minimal residual disease and have the highest efficacy. The bone marrow is the home for blood‐forming hematopoietic stem and progenitor cells. Normal generation of blood and immune cells depends on highly regulated interactions between these stem and progenitor cells with their surrounding environment. Emerging evidence suggests that therapeutic interventions directed at these cellular interdependencies can help boost hematopoiesis and eradicate malignant hematopoietic cells.